Revelation Tangible Book Value Per Share from 2010 to 2024

REVBW Stock  USD 0.01  0.0001  0.81%   
Revelation Biosciences Tangible Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Tangible Book Value Per Share will likely drop to 27.70 in 2024. During the period from 2010 to 2024, Revelation Biosciences Tangible Book Value Per Share regression line of quarterly data had r-squared of  0.08 and coefficient of variation of  307.60. View All Fundamentals
 
Tangible Book Value Per Share  
First Reported
2010-12-31
Previous Quarter
29.15664474
Current Value
27.7
Quarterly Volatility
101.3849706
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Revelation Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revelation Biosciences' main balance sheet or income statement drivers, such as Other Operating Expenses of 7 M, Total Operating Expenses of 7 M or Total Other Income Expense Net of 9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.54. Revelation financial statements analysis is a perfect complement when working with Revelation Biosciences Valuation or Volatility modules.
  
Check out the analysis of Revelation Biosciences Correlation against competitors.
For more information on how to buy Revelation Stock please use our How to Invest in Revelation Biosciences guide.

Latest Revelation Biosciences' Tangible Book Value Per Share Growth Pattern

Below is the plot of the Tangible Book Value Per Share of Revelation Biosciences over the last few years. It is Revelation Biosciences' Tangible Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Revelation Biosciences' overall financial position and show how it may be relating to other accounts over time.
Tangible Book Value Per Share10 Years Trend
Pretty Stable
   Tangible Book Value Per Share   
       Timeline  

Revelation Tangible Book Value Per Share Regression Statistics

Arithmetic Mean32.96
Coefficient Of Variation307.60
Mean Deviation51.52
Median(0.42)
Standard Deviation101.38
Sample Variance10,279
Range404
R-Value0.29
Mean Square Error10,168
R-Squared0.08
Significance0.30
Slope6.47
Total Sum of Squares143,905

Revelation Tangible Book Value Per Share History

2024 27.7
2023 29.16
2022 58.57
2021 -10.58
2020 393.75

About Revelation Biosciences Financial Statements

Revelation Biosciences investors use historical fundamental indicators, such as Revelation Biosciences' Tangible Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Revelation Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Tangible Book Value Per Share 29.16  27.70 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Revelation Stock Analysis

When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.